Point-of-care reader market seen reaching $8.77 billion by 2030

The Business Research Company projects the point-of-care reader market will grow from $5.88 billion in 2026 to $8.77 billion by 2030, powered by AI diagnostics, connected devices and home testing demand. North America led the market in 2025, while Asia-Pacific is expected to be the fastest-growing region.

Why it matters: - Point-of-care readers speed diagnosis outside centralized labs, which can support faster treatment decisions in emergency rooms, rural clinics and home care. - The market’s projected growth signals rising demand for portable diagnostics as healthcare systems face more chronic disease, infectious disease and cost pressure.

What happened: - The Business Research Company published a point-of-care reader market report covering the 2026-2035 outlook. - The market is projected to rise from $5.33 billion in 2025 to $5.88 billion in 2026. - The report forecasts the market will reach $8.77 billion by 2030. - The forecast implies a 10.3% CAGR from 2025 to 2026 and a 10.5% CAGR through 2030. - The company also released a free sample report and the full report online: Download the sample and View the full report.

The details: - Point-of-care readers are compact diagnostic devices that analyze patient samples on-site. - The devices deliver results through test strips, cartridges or biosensors. - The technology bypasses centralized laboratory testing. - The report cites emergency medical settings, infectious disease testing, rural healthcare, glucose monitoring and low-cost testing as major drivers of recent growth. - The forecast period is supported by AI-powered diagnostic interpretation, connected and IoT-enabled readers, home healthcare diagnostics, preventive health programs, and investment in portable molecular and biosensor technologies. - AI integration improves the speed and accuracy of test-result interpretation at the care site. - Home-based and personalized diagnostics are expanding demand for portable, easy-to-use readers. - Rising chronic and infectious diseases continue to increase the need for rapid testing. - The report points to diabetes and cardiovascular disease among the chronic conditions shaping demand. - The report also cites urbanization, unhealthy lifestyles, pollution and population density as factors worsening disease burden. - In May 2025, the Centers for Disease Control and Prevention said chronic obstructive pulmonary disease ranked as the fifth leading cause of death in the U.S. in 2023, with 141,733 fatalities and a 3.8% age-adjusted prevalence of diagnosed COPD in adults. - North America led the market in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The report frames point-of-care readers as part of a broader shift toward decentralized care, where diagnostics move closer to the patient. - AI and connectivity are becoming core features, not add-ons, which suggests future competition will likely focus on speed, interoperability and ease of use. - The regional split suggests mature health systems are driving current revenue, while expanding access and investment are opening faster growth in Asia-Pacific.

What's next: - The Business Research Company expects adoption to keep rising as preventive care, remote monitoring and portable diagnostics expand. - Continued investment in molecular and biosensor technologies may broaden use cases beyond today’s core applications. - The company says its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrix graphics, Excel forecasting dashboards and market-hotspot infographics. - More information is available through the company’s LinkedIn page.

The bottom line: - Point-of-care readers are moving from niche diagnostic tools to a faster-growing healthcare category shaped by AI, connected devices and demand for testing outside traditional labs.